✦ LIBER ✦

Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy

✍ Scribed by Thomas Nelius; Tobias Klatte; Werner de Riese; Stephanie Filleur

Book ID: 106554971
Publisher: Springer Netherlands
Year: 2007
Tongue: English
Weight: 206 KB
Volume: 40
Category: Article
ISSN: 0301-1623
DOI: 10.1007/s11255-007-9221-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy with weekly doc

Combination chemotherapy with weekly docetaxel and estramustine for hormone refractory prostate cancer in Japanese patients

✍ Atsushi Takenaka; Yuji Yamada; Toshifumi Kurahashi; Hideo Soga; Hideaki Miyake; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Circulating levels of interleukin-6 in p

Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer

✍ Drachenberg, Darrel E.; Elgamal, Abdel-Aziz A.; Rowbotham, Ron; Peterson, Mary; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB 👁 2 views

BACKGROUND. ) is a cytokine that plays a central role in host defense due to its wide range of immune and hematopoietic activities. It is found in high levels in human ejaculate, and has recently been found to regulate prostate-specific protein expression in prostate cancer cells through nonsteroida

Is there a role for platinum chemotherap

Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?

✍ William K. Oh; Miah-Hiang Tay; Jiaoti Huang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 3 views

Treatment of androgen-independent, hormo

Treatment of androgen-independent, hormone-refractory prostate cancer with docetaxel in Japanese patients

✍ Yasuhide Miyoshi; Hiroji Uemura; Masafumi Nakamura; Hisashi Hasumi; Shinpei Sugi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 210 KB

First- and second-line chemotherapy with

First- and second-line chemotherapy with docetaxel or mitoxantrone in patients with hormone-refractory prostate cancer : Does sequence matter?

✍ Jorg Michels; Trina Montemurro; Nevin Murray; Christian Kollmannsberger; Kim Ngu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

Clinical outcome of patients with doceta

Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated with second-line cyclophosphamide-based metronomic chemotherapy

✍ Thomas Nelius; Tobias Klatte; Werner de Riese; Allan Haynes; Stephanie Filleur 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 201 KB